Reminder of the period for submission of applications for forced conversion

MD Medical Group IPJSC (“MD Medical”, "Group" or the "Company"; MOEX: MDMG), a leading Russian private healthcare provider, hereby reminds to holders of Global Depositary Receipts (GDRs) of MD MEDICAL GROUP INVESTMENTS PLC (ISIN US55279C2008), representing rights to shares of IPJSC “MD Medical Group” where such rights are recorded by foreign organisations, of the term for submission of applications for forced conversion which is from May 28, 2025 till September 25, 2025.

1) Information about securities of a foreign issuer subject to forced conversion:

• Name of a foreign issuer - JP Morgan Chase Bank, N.A.

• Name, type, category of securities - depositary receipts certifying rights in respect of shares of MD MEDICAL GROUP INVESTMENTS PLC (ISIN — US55279C2008)

2) Information about shares of an international company into which the specified securities of a foreign issuer are converted:

• Name, type, category of securities - ordinary shares

• Registration number - 1-01-16802-A

3) Information about the depository holding the depo account for the depositary programme used to record rights to the international company's shares:

• JSC “Rakurs Invest” (“Rakurs Invest”, or depositary, OGRN 1237700768337, TIN 9703160540).

• Rakurs Invest official website

The Procedure for Forced Conversion of Securities of Foreign Issuer, Certifying Rights in respect of Shares of International Company in accordance with Art. 5 of Federal Law No. 452-FZ dated August 4, 2023 (the “Rules”), applicable to international companies for which JSC “Rakurs Invest” acts as the depositary (including the IPJSC) is available at: https://rakursinvest.ru/services/conversion/?lang=en.

More detailed information on the conversion procedure can also be found in a separate section on the Company's official website: https://www.mcclinics.com/investors/qa/.

Any additional questions the GDR holders may address to the Company’s IR department at ir@mcclinics.ru and “Rakurs Invest” at info@rakursinvest.ru.

About MD Medical Group

MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. Today, the Company manages 86 state-of-the-art healthcare facilities, including 14 multidisciplinary hospitals and 72 out-patient clinics in 35 regions of the Russian Federation. In 2024, MD Medical Group's revenue amounted to RUB 33.1 bln while EBITDA stood at RUB 10.7 bln. The Company's ordinary shares are traded on Moscow Exchange (MOEX: MDMG).